MI LIAN CHUAN BEI PI PA GAO (Shen Neng Herbal Medicines Group Pty Ltd)
While the safety of this medicine was therefore considered to be unacceptable, current data indicate it is unlikely to pose an immediate risk to consumer health and safety. Additionally, the sponsor stopped supply of this medicine in July 2020.
The TGA notified the sponsor that amygdalin was detected in this medicine and required the sponsor to correct the issues. The sponsor cancelled this medicine and withdrew it from further supply.